cell culture ht29 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
96
Structured Review
ATCC
cell culture ht29
Cell Culture Ht29, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 608 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+culture+ht29/NCI-H441/pm42129171-168-0-50
Average 96 stars, based on 608 article reviews
Cell Culture Ht29, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 608 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+culture+ht29/NCI-H441/pm42129171-168-0-50
Average 96 stars, based on 608 article reviews
cell culture ht29 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Cell Culture:Article Title: SREBP1 promotes 5-FU resistance in colorectal cancer cells by inhibiting the expression of caspase7 Article Snippet: Antibodies Caspase-3 (8G10) Rabbit mAb, Caspase-7 (D2Q3L) Rabbit mAb, Caspase-9 (C9) Mouse mAb, PARP Antibody were purchased from Cell Signaling Technology (Danvers, MA,USA); Anti-SREBP1 antibody was purchased from Abcam (Cambridge, MA, USA); β-actin mouse mAb was purchased from (Genscript, JiangSu, China). .. Article Title: FOXP2/SOS1/AKT negative feedback loop inhibits cell proliferation in KRAS-mutant colorectal cancer. Article Snippet: 1 Department of Oncology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin 300121, China 2 Department of Thyroid and Breast Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin 300121, China 3 Tianjin Cancer Institute of Integrative Traditional Chinese and Western Medicine, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin 300121, China 4 School of Medicine, Nankai University, Tianjin 300071, China 5 College of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300121, China 6 Department of Gastrointestinal Surgery 3, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin 301617, China Abstract FOXP2, a member of the Forkhead box transcription factor family, has been implicated in diverse biological processes and malignancies.. However, its role in colorectal cancer (CRC), particularly in the context of KRAS mutations, remains poorly defined.. Here, we analyzed FOXP2 expression in CRC datasets and clinical specimens, and conducted functional assays—including colony formation, cell viability, EdU incorporation, and cell cycle analysis—in KRAS-mutant CRC cell lines with FOXP2 overexpression or knockdown. Article Title: Biomolecular Condensates as Protein Degradation Tools for Intracellular Targets. Article Snippet: .. Article Title: Method of screening for colon cancer using biomarkers Article Snippet: .. Materials and Methods Article Title: Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro. Article Snippet: .. Cell lines and Article Title: miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R/STAT3 pathway in mice Article Snippet: The following primary antibodies were applied in this study: anti-PCNA, anti-BCL-xL (Wanlei Biology, Shenyang, China), anti-STAT3, anti-phospho-STAT3 (Tyr705; Abways Technology, Shanghai, China), anti-IL-6R, and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Affinity, Changzhou, China). .. Article Title: Inhibition of STAT3/Fanconi anemia axis by Nifuroxazide is synthetic lethal with PARP inhibitor and selectively targets breast cancer stem cells Article Snippet: .. Multiple Displacement Amplification:Article Title: Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation. Article Snippet: Proteolysis Targeting Chimeras (PROTACs) represent promising therapeutic modalities for degrading disease-causing proteins.. However, the development of effective PROTACs has been limited by the availability of suitable E3 ligase ligands.. In this study, we demonstrate for the first time that SPOP, an unexplored E3 ligase, can be recruited to degrade target proteins of interest. |